scholarly article | Q13442814 |
P356 | DOI | 10.1136/BMJ.2.5864.450 |
P953 | full work available at URL | https://europepmc.org/articles/PMC1589465 |
https://europepmc.org/articles/PMC1589465?pdf=render | ||
https://syndication.highwire.org/content/doi/10.1136/bmj.2.5864.450 | ||
P932 | PMC publication ID | 1589465 |
P698 | PubMed publication ID | 4712483 |
P2093 | author name string | P. H. Feng | |
E. P. Tock | |||
C. S. Seah | |||
F. J. Jayaratnam | |||
P2860 | cites work | Cyclophosphamide in systemic lupus erythematosus | Q33580225 |
The prognosis of lupus nephritis. Role of clinical-pathologic correlations | Q41940079 | ||
Cyclophosphamide in the treatment of systemic lupus erythematosus | Q50285751 | ||
Corticotropin and cortisone in acute disseminated lupus erythematosus; results of long-term use. | Q51042533 | ||
Multiple late complications of therapy with cyclophosphamide, including ovarian destruction | Q53995512 | ||
Treatment of lupus nephritis with cyclophosphamide. | Q54562889 | ||
CYCLOPHOSPHAMIDE TREATMENT OF RENAL DISEASE IN (NZB × NZW) F1 HYBRID MICE | Q60300214 | ||
Lupus nephritis. Clinical and histologic survey | Q76406469 | ||
THE NATURAL HISTORY OF THE RENAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS | Q76837583 | ||
Cyclophosphamide and infertility | Q93720018 | ||
P433 | issue | 5864 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | systemic lupus erythematosus | Q1485 |
engineering | Q11023 | ||
P304 | page(s) | 450-452 | |
P577 | publication date | 1973-05-01 | |
1973-05-26 | |||
P1433 | published in | The BMJ | Q546003 |
P1476 | title | Cyclophosphamide in treatment of systemic lupus erythematosus: 7 years' experience | |
Cyclophosphamide in Treatment of Systemic Lupus Erythematosus: 7 Years' Experience | |||
P478 | volume | 2 |
Q54200878 | A Sequential Trial Comparing Cyclophosphamide and Azathioprine as Adjuncts in the Treatment of Systemic Lupus Erythematosus* |
Q54495737 | Chlorambucil in the treatment of systemic lupus erythematosus |
Q40154586 | Clinical pharmacology and toxicology of cyclophosphamide: emphasis on use in rheumatic diseases |
Q34250896 | Clinical trials in lupus nephritis |
Q40497391 | Clinical use of immunosuppressive drugs: part I |
Q40197212 | Cyclophosphamide (Cytoxan). A review on relevant pharmacology and clinical uses |
Q36269226 | Immunosuppressive Therapy in Rheumatic Disease |
Q40883177 | Immunosuppressive drug therapy in lupus nephritis |
Q38591478 | Mechanisms of action and clinical applications of cytotoxic drugs in rheumatic disorders |
Q33824546 | Recent advances in the immunopathogenesis of systemic lupus erythematosus |
Q37800291 | Two perspectives on lupus: patient and doctor |
Search more.